| Chronic myeloid leukemia stem cells M Houshmand, G Simonetti, P Circosta, V Gaidano, A Cignetti, ... Leukemia 33 (7), 1543-1556, 2019 | 171 | 2019 |
| Tissue engineering of peripheral nerves B Battiston, S Raimondo, P Tos, V Gaidano, C Audisio, A Scevola, ... International Review of Neurobiology 87, 227-249, 2009 | 108 | 2009 |
| Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine A Valencia, E Masala, A Rossi, A Martino, A Sanna, F Buchi, F Canzian, ... Leukemia 28 (3), 621-628, 2014 | 95 | 2014 |
| Quality of life and physicians' perception in myelodysplastic syndromes EN Oliva, C Finelli, V Santini, A Poloni, V Liso, D Cilloni, S Impera, ... American journal of blood research 2 (2), 136, 2012 | 71 | 2012 |
| Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors S Sainas, AC Pippione, E Lupino, M Giorgis, P Circosta, V Gaidano, ... Journal of medicinal chemistry 61 (14), 6034-6055, 2018 | 67 | 2018 |
| Targeting chronic myeloid leukemia stem/progenitor cells using venetoclax-loaded immunoliposome M Houshmand, F Garello, R Stefania, V Gaidano, A Cignetti, M Spinelli, ... Cancers 13 (6), 1311, 2021 | 28 | 2021 |
| A clinically applicable approach to the classification of B-cell non-Hodgkin lymphomas with flow cytometry and machine learning V Gaidano, V Tenace, N Santoro, S Varvello, A Cignetti, G Prato, G Saglio, ... Cancers 12 (6), 1684, 2020 | 27 | 2020 |
| The synergism between DHODH inhibitors and dipyridamole leads to metabolic lethality in acute myeloid leukemia V Gaidano, M Houshmand, N Vitale, G Carrà, A Morotti, V Tenace, ... Cancers 13 (5), 1003, 2021 | 25 | 2021 |
| Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold … S Sainas, M Giorgis, P Circosta, V Gaidano, D Bonanni, AC Pippione, ... Journal of Medicinal Chemistry 64 (9), 5404-5428, 2021 | 24 | 2021 |
| Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia D Cilloni, S Carturan, E Bracco, V Campia, V Rosso, D Torti, C Calabrese, ... Leukemia research 37 (5), 520-530, 2013 | 20 | 2013 |
| Inhibition of bromodomain and extra‐terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia G Carrà, P Nicoli, MF Lingua, B Maffeo, A Cartellà, P Circosta, ... Journal of Cellular and Molecular Medicine 24 (2), 1650-1657, 2020 | 19 | 2020 |
| Prognostic significance of The Wilms’ Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia J Petiti, V Rosso, ML Iacono, C Calabrese, E Signorino, V Gaidano, ... Leukemia research 67, 6-11, 2018 | 19 | 2018 |
| Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience G Calabretto, E Attardi, A Teramo, V Trimarco, S Carraro, S Mossuto, ... Leukemia 36 (7), 1947-1950, 2022 | 18 | 2022 |
| SARS‐CoV‐2 in myelodysplastic syndromes: a snapshot from early Italian experience S Mossuto, E Attardi, F Alesiani, E Angelucci, E Balleari, M Bernardi, ... Hemasphere 4 (5), e483, 2020 | 15 | 2020 |
| Post-transplant cyclophosphamide and tacrolimus—mycophenolate mofetil combination governs GVHD and immunosuppression need, reducing late toxicities in allogeneic peripheral … F Carnevale-Schianca, D Caravelli, S Gallo, P Becco, L Paruzzo, ... Journal of clinical medicine 10 (6), 1173, 2021 | 14 | 2021 |
| The Wilms’ tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker … D Gallo, P Nicoli, C Calabrese, V Gaidano, J Petiti, V Rosso, E Signorino, ... Cancer medicine 5 (7), 1650-1653, 2016 | 14 | 2016 |
| Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold … S Sainas, M Giorgis, P Circosta, G Poli, M Alberti, A Passoni, V Gaidano, ... Journal of Medicinal Chemistry 65 (19), 12701-12724, 2022 | 11 | 2022 |
| DHODH inhibitors and leukemia: an emergent interest for new myeloid differentiation agents S Sainas, AC Pippione, D Boschi, V Gaidano, P Circosta, A Cignetti, ... Drugs of the Future 43 (11), 823-834, 2018 | 11 | 2018 |
| Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISH V Rosso, E Bracco, R Pedrola, S Carturan, E Signorino, J Petiti, ... Biomarker Research 3, 1-5, 2015 | 10 | 2015 |
| Shedding light on targeting chronic myeloid leukemia stem cells M Houshmand, A Kazemi, A Anjam Najmedini, MS Ali, V Gaidano, ... Journal of Clinical Medicine 10 (24), 5805, 2021 | 9 | 2021 |
